Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effect of misclassification in screening trials: a simulation study.

Nancy A Obuchowski1, Michael L Lieber

  • 1Department of Quantitative Health Sciences, Cleveland Clinic, OH 44195, USA. obuchon@ccf.org

Contemporary Clinical Trials
|July 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Study Design and Analysis of MR Imaging Markers Through Measurement Error Modeling.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Scalable Clinical Annotation with Location Evidence (SCALE).

Computers in biology and medicine·2025
Same author

Association of Statistical Methodology and Design in Preclinical Animal Studies With Successful Translation Into Clinical Phase 2 Trials.

Neurology·2025
Same author

Objective Task-Based Evaluation of Quantitative Medical Imaging Methods: Emerging Frameworks and Future Directions.

PET clinics·2025
Same author

Understanding Repeatability and Reproducibility Coefficients for Quantitative Imaging Biomarkers.

Radiology·2025
Same author

ISIT-GEN: An in silico imaging trial to assess the inter-scanner generalizability of CTLESS for myocardial perfusion SPECT on defect-detection task.

ArXiv·2025
Same journal

The sequential cohort randomized clinical trial: A study design for community-engaged clinical research in a rural American Indian community.

Contemporary clinical trials·2026
Same journal

Rationale, design, and statistical analysis plan for a randomized, double-blind, placebo-controlled trial of Limosilactobacillus reuteri to support mother-infant bonding and maternal socioemotional functioning in postpartum women at increased risk for postpartum depression.

Contemporary clinical trials·2026
Same journal

Effectiveness of clinical trial recruitment strategies in a safety-net hospital.

Contemporary clinical trials·2026
Same journal

Are older adult research participants representative of the general population? Results from 19 clinical studies at one academic research center.

Contemporary clinical trials·2026
Same journal

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD Caregiver Oncology Needs Evaluation Tool (CONNECT) trial.

Contemporary clinical trials·2026
Same journal

Rationale and design of a CArdiac rehabilitation program on the prevention of CardioTOXicity in breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: A randomized, active control group, open-label trial.

Contemporary clinical trials·2026
See all related articles

Misclassification in screening trials can reduce study power, especially when events are falsely attributed to disease. Careful design and sample size calculations are crucial for accurate randomized clinical trial (RCT) results.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Epidemiology

Background:

  • Misclassification of study endpoints is a known issue in randomized clinical trials (RCTs) for screening tests.
  • The impact of misclassification on study power, type I error rate, and risk ratio estimates requires further in-depth investigation.

Purpose of the Study:

  • To investigate the effects of misclassification on study power, type I error rate, and risk ratio estimates in screening trials.
  • To analyze the differential impact of various types and amounts of misclassification on study outcomes.

Main Methods:

  • A Markov model was developed to simulate disease natural history and screening effects.
  • Simulations were conducted for two-arm RCTs, varying misclassification types and levels.
  • The impact on disease-specific mortality and symptom incidence endpoints was assessed.

Related Experiment Videos

Main Results:

  • Failure to identify true disease events had minimal impact on risk ratio estimates and study power.
  • False identification of events as disease-attributable significantly reduced study power.
  • The type of misclassification critically influences the observed effects.

Conclusions:

  • Researchers must anticipate and address potential misclassification in screening RCTs.
  • Study designs should prioritize minimizing misclassification errors.
  • The influence of misclassification on statistical power must inform sample size calculations for screening trials.